(Q57224275)

M Swanberg

5

0 references

Jinko Graham

J Graham

10

0 references

Caroline Graff

C Graff

13

0 references

Mona Landin-Olsson

M Landin-Olsson

16

0 references

Ingrid Kockum

I Kockum

28

0 references

Leonid Padyukov

L Padyukov

6

0 references

Lars Alfredsson

L Alfredsson

25

0 references

Johnny Ludvigsson

J Ludvigsson

22

0 references

Tommy Olsson

27

T Olsson

0 references

Marju Orho-Melander

11

M Orho-Melander

0 references

Per Larsson

20

H Larsson

0 references

author name string

A Gyllenberg

1

0 references

S Asad

3

0 references

F Piehl

4

0 references

B Van Yserloo

7

0 references

E A Rutledge

8

0 references

B McNeney

9

0 references

C Forsell

14

0 references

K Åkesson

15

0 references

A Carlsson

17

0 references

G Forsander

18

0 references

S A Ivarsson

19

0 references

B Lindblad

21

0 references

C Marcus

23

0 references

Å Lernmark

24

0 references

K Åkesson

Genetic analysis of type 1 diabetes using whole genome approaches

26

0 references

publication date

11 October 2012

0 references

published in

Genes and Immunity

0 references

volume

13

0 references

issue

8

0 references

page(s)

632-640

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

MHC2TA is associated with rheumatoid arthritis in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Role of the MHC2TA gene in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

The genetics of HLA-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

The Swedish childhood diabetes study--results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

A dynamic programming algorithm for haplotype block partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

HaploBlockFinder: haplotype block analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Calculating measures of biological interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Recoding preventive exposures to get valid measures of interaction on an additive scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Classifying diabetes according to the new WHO clinical stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

Islet Cell and Thyrogastric Antibodies in 633 Consecutive 15- to 34-Yr-Old Patients in the Diabetes Incidence Study in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

The interleukin 23 receptor gene in multiple sclerosis: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

Variation in the BMP2 gene: bone mineral density and ultrasound in young adult and elderly women

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2012.44

7 January 2021